Mexico - Delayed Quote MXN
10x Genomics, Inc. (TXG.MX)
150.00
-5.77
(-3.70%)
At close: April 4 at 8:34:22 AM CST
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
610,785
610,785
618,727
516,409
490,490
Cost of Revenue
196,303
196,303
209,414
120,386
74,091
Gross Profit
414,482
414,482
409,313
396,023
416,399
Operating Expense
609,041
609,041
613,662
563,967
469,312
Operating Income
-194,559
-194,559
-204,349
-167,944
-52,913
Net Non Operating Interest Income Expense
18,444
18,444
16,873
6,171
-660
Other Income Expense
-1,585
-1,585
-61,287
-198
-142
Pretax Income
-177,700
-177,700
-248,763
-161,971
-53,715
Tax Provision
4,927
4,927
6,336
4,029
4,508
Net Income Common Stockholders
-182,627
-182,627
-255,099
-166,000
-58,223
Diluted NI Available to Com Stockholders
-182,627
-182,627
-255,099
-166,000
-58,223
Basic EPS
-1.52
-1.52
-2.18
-1.46
-0.53
Diluted EPS
-1.52
-1.52
-2.18
-1.46
-0.53
Basic Average Shares
119,695.66
120,451.55
117,165.04
113,858.68
110,347.94
Diluted Average Shares
119,695.66
120,451.55
117,165.04
113,858.68
110,347.94
Total Operating Income as Reported
-194,559
-194,559
-265,329
-167,944
-52,253
Total Expenses
805,344
805,344
823,076
684,353
543,403
Net Income from Continuing & Discontinued Operation
-182,627
-182,627
-255,099
-166,000
-58,223
Normalized Income
-182,627
-182,627
-206,924.80
-166,000
-58,704.80
Interest Income
18,448
18,448
16,906
6,647
206
Interest Expense
4
4
33
476
866
Net Interest Income
18,444
18,444
16,873
6,171
-660
EBIT
-177,696
-177,696
-248,730
-161,495
-52,849
EBITDA
-133,988
-133,988
-205,111
-128,489
-24,595
Reconciled Cost of Revenue
196,303
196,303
209,414
120,386
74,091
Reconciled Depreciation
43,708
43,708
43,619
33,006
28,254
Net Income from Continuing Operation Net Minority Interest
-182,627
-182,627
-255,099
-166,000
-58,223
Total Unusual Items Excluding Goodwill
--
--
-60,980
--
660
Total Unusual Items
--
--
-60,980
--
660
Normalized EBITDA
-133,988
-133,988
-144,131
-128,489
-25,255
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
-12,805.80
--
178.20
12/31/2021 - 4/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade